The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 10.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (16 analysts) rates it buy, with a mean price target of $46.
CenterPoint Energy
CNP · a US exchange · USD · Market cap $26.2B · 8,794 employees
CenterPoint Energy, Inc.
FAIL · Does not pass the screenAt the last full screen
2026-09-09
Screened 2026-09-09 · the tape above runs as of 11:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its distribution label.
CenterPoint Energy holds its Distribution at $39.77. The statistical read favours the sellers, held for 1 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the sellers, held for 1 days |
| Price at the screen | $39.77 |
| Valuation | 23.67 trailing · 19.06 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.45 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 49.38% | Below 33% | Interest-bearing debt is 49.4% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 1.10% | Below 33% | Cash held in interest-bearing accounts and securities is 1.1% of assets, under the one-third limit. | Pass |
| Receivables | 1.81% | Below 49% | Money owed to the company is 1.8% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades above our $38.65 fair value estimate, narrow competitive moat, 10.70% revenue growth.
Fair value range in USD, drawn from the 2026-09-09 screen. The gold marker is the market price at the same screen. The price runs 2.8% above the base estimate.
Third-party analyst targets: 16 covering, consensus None. The average target sits +16% from the screen price.
Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-09 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsLights stay on but debt weighs heavy
Picture a power bill that arrives every month without fail. CenterPoint Energy delivers electricity across the US yet its balance sheet carries too much debt for our ethical screen to clear. The shares trade at $43 against a fair value of $39, revenue inches forward just 2 percent a year, and the forward multiple sits at 20.7 times.
We pass because the numbers do not add up on either valuation or ethics. Profit margins of 11 percent and a 10 percent return on equity look ordinary for a narrow-moat regulated utility, while the debt ratio breach rules the name out regardless of what sixteen analysts say.
The real risk is that steady cash flows mask leverage that could bite if rates stay high or regulators push back on returns. Peak earnings at a high multiple often signal a value trap rather than a bargain.
Analysis, not advice.
| Forward P/E | 19.1xpriced for continued growth |
| Trailing P/E | 23.7xa premium valuation |
| EPS, trailing | 1.68 |
| EPS, forward | 2.09 |
| Revenue growth | +10.7%steady growth |
| Profit margin | 11.6%thin but positive margins |
| Return on equity | 9.8%a modest return on shareholder capital |
| FCF yield | -19.82% |
| Dividend yield | 221.00% |
| Debt to equity | 2.10heavy leverage: higher risk if revenue softens |
| Current ratio | 1.12adequate liquidity, worth monitoring |
| Beta | 0.45barely tracks the market's swings |
| Short interest, float | 0.08% |
| 52-week range | 37.22 - 45.26 |
| Moat | NARROW |
| Market cap | $26.2B |
| Employees | 8,794 |
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeCNP trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (16 analysts) rates it buy, with a mean price target of $46.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (16 analysts) rates it buy, with a mean price target of $46.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Top Research Reports for Interactive Brokers, Danaher & S&P Global Zacks · 16 Jul 2026
- Five Energy Stocks Riding Texas's Data Center Power Boom Oilprice.com · 5 Jul 2026
- What to Expect From CenterPoint Energy's Q2 2026 Earnings Report Barchart · 2 Jul 2026
- CNP vs. ES: Which Utility Stock Offers Better Return Potential? Zacks · 23 Jun 2026
- Ubiquiti Upgraded, Reddit Downgraded: Updated Rankings on Top Blue-Chip Stocks InvestorPlace · 22 Jun 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-01 | MALIK THADDEUS J | Director | 4,037 | · | |
| 2026-05-01 | DUGANIER BARBARA J. | Director | 4,037 | · | |
| 2026-05-01 | CLOONAN WENDOLYNN MONTOYA | Director | 4,037 | · | |
| 2026-05-01 | RAQUELLE WOOTEN LEWIS | Director | 4,037 | · | |
| 2026-05-01 | FITCH LAURIE LEE | Director | 4,037 | · | |
| 2026-05-01 | MIRANDA MANUEL BENITO | Director | 4,037 | · | |
| 2026-05-01 | HERMAN MICHAEL ALBERT | Director | 4,037 | · | |
| 2026-05-01 | POUND THEODORE F III | Director | 4,037 | · | |
| 2026-05-01 | FRANKLIN CHRISTOPHER H | Director | 4,037 | · | |
| 2026-05-01 | SEAVERS DEAN | Director | 4,037 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $42.04 | +1.7% | $0.23 | $1,022 | +2.2% |
| 2 months | $43.15 | -1.0% | $0.23 | $996 | -0.4% |
| 3 months | $43.16 | -1.0% | $0.23 | $995 | -0.5% |
| 6 months | $36.92 | +15.7% | $0.46 | $1,170 | +17.0% |
| 1 year | $35.45 | +20.5% | $0.90 | $1,231 | +23.1% |
| 2 years | $28.97 | +47.5% | $1.75 | $1,536 | +53.6% |
| 3 years | $26.80 | +59.5% | $2.54 | $1,690 | +69.0% |
| 5 years | $23.05 | +85.4% | $3.95 | $2,025 | +102.5% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever CNP does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.